Applications of Chromosomal Microarray Analysis (CMA) in pre- and postnatal Diagnostic: advantages, limitations and concerns

Size: px
Start display at page:

Download "Applications of Chromosomal Microarray Analysis (CMA) in pre- and postnatal Diagnostic: advantages, limitations and concerns"

Transcription

1 Applications of Chromosomal Microarray Analysis (CMA) in pre- and postnatal Diagnostic: advantages, limitations and concerns جواد کریمزاد حق PhD of Medical Genetics آزمايشگاه پاتوبيولوژي و ژنتيك پارسه

2 Array CGH (comparative genomic hybridization)/ (single nucleotide polymorphism) SNP Array I:Technical Principles II: Clinical Applications

3 I:Technical Principles Array-CGH, SNP-Array

4 acgh: Array comparative genomic hybridization (also microarray-based comparative genomic hybridization, array CGH, acgh) is a molecular cytogenetic technique for the detection of chromosomal copy number changes on a genome wide and high-resolution scale.

5 SNP array is a type of DNA microarray which is used to detect polymorphisms within a population. A single nucleotide polymorphism (SNP), a variation at a single site in DNA, is the most frequent type of variation in the genome.

6 Differences in the ability to resolve genomic changes between these arrays I:Array CGH Gain Detection of CNVs Loss Detection of CNVs (Unbalanced chromosomal rearrangements) single-exon copy number variants (CNVs) Resolution 8x60k, 4x180k, 2x400k, 1M SurePrint G3 Custom CGH+SNP (LOH-Analayse, Delectation of UPD) Agilent II: SNP Array Gain Detection of CNVs Loss Detection of CNVs (Unbalanced chromosomal rearrangements) Determining disease susceptibility (Genome wide association study) Loss Of Heterozygosity (LOH) higher sensitivity for the detection of low-level mosaic aneuploidies and chimerism indicate uniparental disomy (UPD) Detection of Polyploidy, MaternalContamination Parental DNA needed!! Resolution 2.7 M, 1.8M (SNP 6.0) Affymetrix

7

8 DNA Extraction To Annotation DGV/DECIPHER/ISCA/UCSC/OMIM, Gene Reviews and recently published reviews Benign (Literature reports! no genes!! enriched in repetitive sequences, short size), Definitely pathologic (Literature reports! Dom. Pattern (HI), high densities of functional elements, large size) Uncertain clinical Significance (likely pathologic: small database reports, one gene!//likely benign: small databases polymorph in general population// unclassified: Dosage effect of, genes is unknown, Inherited Incidental Finding (for. example: risk of neoplasia :TP53,RB) Difficult Interpretation by high resolution(by high resolution)

9 Copy Number Variations (CNVs) Copy number variation is a type of structural variation: specifically, it is a type of duplication or deletion event that affects a considerable number of base pairs ~ % of the human genome can be classified as copy number variations and approximately 100 genes that can be completely deleted without producing apparent phenotypic consequences. Nature Reviews Genetics. 16:

10

11

12

13

14 II: Clinical Applications

15

16

17 The majority (>95%) of benign CNVs in humans are <100 kb in size

18 Clinical Applications 1. PGD/PGS/PND 2. Abortion 3. Ultrasonographic detected structural abnormalities of fetus 4. non-syndromic developmental delay/intellectual disability (DD/ID), Multiple Congenital Anomalies (MCA) not specific to a well-delineated genetic syndrome, Autism Spectrum Disorders (ASD) and children with growth retardation and speech delay

19 1. PGD/PGS/PND PGS identifies chromosomally normal embryos ("euploid" embryos) for transfer to the uterus in the last step of an IVF cycle. Patients with a history of recurrent miscarriage or failed IVF cycles, which can be linked to chromosomal abnormality, may benefit from PGS. In addition, patients may also undergo PGS with the goal of transferring a single embryo. Blastomer biopsy of a 3-day-old embryo Trophectoderm biopsy of a 5-day-old embryo

20 2. Abortions In about 50% of first trimester spontaneous abortion the cause remains undetermined after standard cytogenetic investigation. array-cgh: detects abnormalities in a further ~10% of spontaneous abortion specimens considered to be normal using standard cytogenetic methods Spontaneous abortion and stillbirth by array-based comparative genomic hybridization 43 fetuses with spontaneous abortion and stillbirth. 32 (74.4%) of the samples, which included 26 (60%) aneuploidies and 10 (23%) pathogenic CNV Jun;32(3): doi: /cma.j.issn

21 3. Ultrasonographic detected structural abnormalities of fetus Chromosomal Microarray Analysis (CMA) can identify also imbalanced chromosomal aberration in approximately 6% of fetuses with ultrasonographic abnormalities with a normal karyotype result. Anencephaly Microcephaly Cleft palate Polyhydramnios Encephalocele Cystic hygroma Hydrops fetalis Dandy-Walker malformation Polydactyly Holoprosencephaly Oligohydramnios

22 Result: arr[hg19] 22q11.21( _ )x3 Microarray CGH The gain is between locus q11.21 starting from bp to bp ranging 3.23Mb.

23 Two breakpoints between USP18 and CLTCL1 locus in the centromer section and LZTR1 and HIC2 locus in the telomeric section, that contains a genome duplication sizing about 2-3 Mb. This microduplication was also identified exactly in the father of the fetus.

24 4. non-syndromic developmental delay/intellectual disability (DD/ID), multiple congenital anomalies (MCA) not specific to a well-delineated genetic syndrome, autism spectrum disorders (ASD) and children with growth retardation and speech delay Array CGH is recommended as the first-tier evaluation in individuals with developmental disabilities or congenital anomalies not specific to a well-delineated mono genetic syndrome. The value of acgh screening as a first-tier test in children with multiple congenital anomalies has been studied and consensus adopted. Disease-causing CNVs are found in 5% 10% of cases of autism. Among 1792 patients (DD/MCA/ASD), 13.1% had clinically relevant results, either abnormal (n 131; 7.3%) or variants of possible significance (VPS; n 104; 5.8%). Genetics IN Medicine Volume 13, Number 9, September 2011

25 Confirm of array results /FISH /Realtime-PCR or PCR-capillary

26

27 Conclusion Array CGH/SNP Indications Example I: A parents with known balanced Translocation or marker-chromosome or a ring X-chromosome, Inversion wit an affected person, de novo translocation (8-10%) (one of parents has an chromosomal rearrangement without clinical features) PGD/PGS/CVS/Amniocentesis/cordocentesis Example II: IVF Failures, Recurrent pregnancy loss, Abortions PGS/POC Example III: Fetus with structural anomalies IUFD, IUGR : QF- PCR, FISH, MLPA and karyotype results are normal! Example IV: ID/DD, ASD, MCA Prenatal diagnostic Postnatal diagnostic For Choosing of suitable Array resolutions the physicians should be counseling with Genetics-Laboratories (Examples: 60 k for Abortion, 180 k for ASD)

28

CHROMOSOMAL MICROARRAY (CGH+SNP)

CHROMOSOMAL MICROARRAY (CGH+SNP) Chromosome imbalances are a significant cause of developmental delay, mental retardation, autism spectrum disorders, dysmorphic features and/or birth defects. The imbalance of genetic material may be due

More information

Sharan Goobie, MD, MSc, FRCPC

Sharan Goobie, MD, MSc, FRCPC Sharan Goobie, MD, MSc, FRCPC Chromosome testing in 2014 Presenter Disclosure: Sharan Goobie has no potential for conflict of interest with this presentation Objectives Review of standard genetic investigations

More information

Approach to Mental Retardation and Developmental Delay. SR Ghaffari MSc MD PhD

Approach to Mental Retardation and Developmental Delay. SR Ghaffari MSc MD PhD Approach to Mental Retardation and Developmental Delay SR Ghaffari MSc MD PhD Introduction Objectives Definition of MR and DD Classification Epidemiology (prevalence, recurrence risk, ) Etiology Importance

More information

Challenges of CGH array testing in children with developmental delay. Dr Sally Davies 17 th September 2014

Challenges of CGH array testing in children with developmental delay. Dr Sally Davies 17 th September 2014 Challenges of CGH array testing in children with developmental delay Dr Sally Davies 17 th September 2014 CGH array What is CGH array? Understanding the test Benefits Results to expect Consent issues Ethical

More information

National Medical Policy

National Medical Policy National Medical Policy Subject: Policy Number: Single Nucleotide Polymorphism (SNP) Chromosomal Microarray Analysis for Prenatal Testing and Intellectual Disability, Developmental Delay, and Multiple

More information

SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY.

SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY. SAMPLE REPORT SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY. RESULTS SNP Array Copy Number Variations Result: GAIN,

More information

SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY.

SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY. SAMPLE REPORT SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY. RESULTS SNP Array Copy Number Variations Result: LOSS,

More information

Genetic Testing 101: Interpreting the Chromosomes

Genetic Testing 101: Interpreting the Chromosomes Genetic Testing 101: Interpreting the Chromosomes Kristin Lindstrom, MD Division of Genetics and Metabolism Phoenix Children s Hospital AzAAP Pediatrics in the Red Rocks I have no disclosures for this

More information

CHROMOSOME MICROARRAY TESTING

CHROMOSOME MICROARRAY TESTING CHROMOSOME MICROARRAY TESTING UnitedHealthcare Commercial Medical Policy Policy Number: 2017T0559J Effective Date: August 1, 2017 Table of Contents Page INSTRUCTIONS FOR USE... 1 BENEFIT CONSIDERATIONS...

More information

CURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE. Dr. Bahar Naghavi

CURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE. Dr. Bahar Naghavi 2 CURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE Dr. Bahar Naghavi Assistant professor of Basic Science Department, Shahid Beheshti University of Medical Sciences, Tehran,Iran 3 Introduction Over 4000

More information

CHROMOSOME MICROARRAY TESTING (NON-ONCOLOGY CONDITIONS)

CHROMOSOME MICROARRAY TESTING (NON-ONCOLOGY CONDITIONS) CHROMOSOME MICROARRAY TESTING (NON-ONCOLOGY CONDITIONS) UnitedHealthcare Oxford Clinical Policy Policy Number: LABORATORY 016.12 T2 Effective Date: June 1, 2018 Table of Contents Page INSTRUCTIONS FOR

More information

Multiple Copy Number Variations in a Patient with Developmental Delay ASCLS- March 31, 2016

Multiple Copy Number Variations in a Patient with Developmental Delay ASCLS- March 31, 2016 Multiple Copy Number Variations in a Patient with Developmental Delay ASCLS- March 31, 2016 Marwan Tayeh, PhD, FACMG Director, MMGL Molecular Genetics Assistant Professor of Pediatrics Department of Pediatrics

More information

Prenatal Diagnosis: Are There Microarrays in Your Future?

Prenatal Diagnosis: Are There Microarrays in Your Future? Financial Disclosure UCSF Antepartum Intrapartum Management Course June 8 I have no financial relationship with any aspect of private industry Prenatal Diagnosis: Are There Microarrays in Your Future?

More information

Genetic Testing for the Developmental Delay/Intellectual Disability, Autism Spectrum Disorder, and Congenital Anomalies

Genetic Testing for the Developmental Delay/Intellectual Disability, Autism Spectrum Disorder, and Congenital Anomalies Genetic Testing for the Developmental Delay/Intellectual Disability, Autism Spectrum Disorder, and Congenital Anomalies Policy Number: 2.04.59 Last Review: 5/2018 Origination: 5/2015 Next Review: 5/2019

More information

Faravareh Khordadpoor (PhD in molecular genetics) 1- Tehran Medical Genetics Laboratory 2- Science and research branch, Islamic Azad University

Faravareh Khordadpoor (PhD in molecular genetics) 1- Tehran Medical Genetics Laboratory 2- Science and research branch, Islamic Azad University Faravareh Khordadpoor (PhD in molecular genetics) 1- Tehran Medical Genetics Laboratory 2- Science and research branch, Islamic Azad University 1395 21 مشاوره ژنتیک و نقش آن در پیش گیری از معلولیت ها 20

More information

Practical challenges that copy number variation and whole genome sequencing create for genetic diagnostic labs

Practical challenges that copy number variation and whole genome sequencing create for genetic diagnostic labs Practical challenges that copy number variation and whole genome sequencing create for genetic diagnostic labs Joris Vermeesch, Center for Human Genetics K.U.Leuven, Belgium ESHG June 11, 2010 When and

More information

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY Original Issue Date (Created): April 26, 2011 Most Recent Review Date (Revised): January 28, 2014 Effective Date: June 1, 2014 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT

More information

Section: Medicine Effective Date: January15, 2016 Subsection: Pathology/Laboratory Original Policy Date: December 7, 2011 Subject:

Section: Medicine Effective Date: January15, 2016 Subsection: Pathology/Laboratory Original Policy Date: December 7, 2011 Subject: Section: Medicine Effective Date: January15, 2016 Last Review Status/Date: December 2015 Page: 1 of 22 Microarray Analysis and Next-Generation Autism Spectrum Disorder and/or Congenital Description Chromosomal

More information

Cytogenetics 101: Clinical Research and Molecular Genetic Technologies

Cytogenetics 101: Clinical Research and Molecular Genetic Technologies Cytogenetics 101: Clinical Research and Molecular Genetic Technologies Topics for Today s Presentation 1 Classical vs Molecular Cytogenetics 2 What acgh? 3 What is FISH? 4 What is NGS? 5 How can these

More information

SEAMLESS CGH DIAGNOSTIC TESTING

SEAMLESS CGH DIAGNOSTIC TESTING SEAMLESS CGH DIAGNOSTIC TESTING GENETISURE DX POSTNATAL ASSAY Informed decisions start with a complete microarray platform for postnatal analysis For In Vitro Diagnostic Use INTENDED USE: GenetiSure Dx

More information

Genetic Testing for Single-Gene and Multifactorial Conditions

Genetic Testing for Single-Gene and Multifactorial Conditions Clinical Appropriateness Guidelines Genetic Testing for Single-Gene and Multifactorial Conditions EFFECTIVE DECEMBER 1, 2017 Appropriate.Safe.Affordable 2017 AIM Specialty Health 2069-1217 Table of Contents

More information

Medical Policy. MP Invasive Prenatal (Fetal) Diagnostic Testing

Medical Policy. MP Invasive Prenatal (Fetal) Diagnostic Testing Medical Policy MP 2.04.116 BCBSA Ref. Policy: 2.04.116 Last Review: 04/30/2018 Effective Date: 04/30/2018 Section: Medicine Related Policies 2.04.59 Genetic Testing for Developmental Delay/Intellectual

More information

Protocol. Genetic Testing for Developmental Delay and Autism Spectrum Disorder

Protocol. Genetic Testing for Developmental Delay and Autism Spectrum Disorder Genetic Testing for Developmental Delay and Autism Spectrum (20459, 20483, 20481) Medical Benefit Effective Date: 01/01/18 Next Review Date: 09/18 Preauthorization Yes Review Dates: 09/10, 09/11, 03/12,

More information

Implementation of the DDD/ClinGen OGT (CytoSure v3) Microarray

Implementation of the DDD/ClinGen OGT (CytoSure v3) Microarray Implementation of the DDD/ClinGen OGT (CytoSure v3) Microarray OGT UGM Birmingham 08/09/2016 Dom McMullan Birmingham Women's NHS Trust WM chromosomal microarray (CMA) testing Population of ~6 million (10%)

More information

CLINICAL MEDICAL POLICY

CLINICAL MEDICAL POLICY Policy Name: Policy Number: Approved By: CLINICAL MEDICAL POLICY Chromosomal Microarray Analysis: Comparative Genomic Hybridization (CGH) and Single Nucleotide Polymorphism (SNP) MP-012-MD-WV Medical Management

More information

CNV Detection and Interpretation in Genomic Data

CNV Detection and Interpretation in Genomic Data CNV Detection and Interpretation in Genomic Data Benjamin W. Darbro, M.D., Ph.D. Assistant Professor of Pediatrics Director of the Shivanand R. Patil Cytogenetics and Molecular Laboratory Overview What

More information

Whole-Genome SNP Array Analysis Genomic Complexity and Clinical Relevance in Prenatal, Postnatal, and Oncology Testing

Whole-Genome SNP Array Analysis Genomic Complexity and Clinical Relevance in Prenatal, Postnatal, and Oncology Testing The Evolution of Cytogenetics Testing Whole-Genome SNP Array Analysis Genomic Complexity and Clinical Relevance in Prenatal, Postnatal, and Oncology Testing Mark Micale, Ph.D., F.A.C.M.G. Medical Director,

More information

Clinical evaluation of microarray data

Clinical evaluation of microarray data Clinical evaluation of microarray data David Amor 19 th June 2011 Single base change Microarrays 3-4Mb What is a microarray? Up to 10 6 bits of Information!! Highly multiplexed FISH hybridisations. Microarray

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Invasive Prenatal (Fetal) Diagnostic Testing File Name: Origination: Last CAP Review: Next CAP Review: Last Review: invasive_prenatal_(fetal)_diagnostic_testing 12/2014 3/2018

More information

Chromosome microarray analysis in routine prenatal diagnosis practice: a prospective study on 3000 consecutive clinical cases

Chromosome microarray analysis in routine prenatal diagnosis practice: a prospective study on 3000 consecutive clinical cases Chromosome microarray analysis in routine prenatal diagnosis practice: a prospective study on 3000 consecutive clinical cases Fiorentino F, Napoletano S, Caiazzo F, Sessa M, Bono S, Spizzichino L, Gordon

More information

PATIENT CONSENT FORM Preimplantation Genetic Screening (PGS) 24 Chromosome Aneuploidy and Translocation Screening with acgh

PATIENT CONSENT FORM Preimplantation Genetic Screening (PGS) 24 Chromosome Aneuploidy and Translocation Screening with acgh PREIMPLANTATION GENETIC SCREENING FOR ANEUPLOIDY SCREENING INTRODUCTION Preimplantation genetic screening (PGS) is used in conjunction with in-vitro fertilization (IVF) to screen embryos for numerical

More information

What s the Human Genome Project Got to Do with Developmental Disabilities?

What s the Human Genome Project Got to Do with Developmental Disabilities? What s the Human Genome Project Got to Do with Developmental Disabilities? Disclosures Neither speaker has anything to disclose. Phase Two: Interpretation Officially started in October 1990 Goals of the

More information

Generating Spontaneous Copy Number Variants (CNVs) Jennifer Freeman Assistant Professor of Toxicology School of Health Sciences Purdue University

Generating Spontaneous Copy Number Variants (CNVs) Jennifer Freeman Assistant Professor of Toxicology School of Health Sciences Purdue University Role of Chemical lexposure in Generating Spontaneous Copy Number Variants (CNVs) Jennifer Freeman Assistant Professor of Toxicology School of Health Sciences Purdue University CNV Discovery Reference Genetic

More information

Genetic Counselling in relation to genetic testing

Genetic Counselling in relation to genetic testing Genetic Counselling in relation to genetic testing Dr Julie Vogt Consultant Geneticist West Midlands Regional Genetics Service September 2016 Disclosures for Research Support/P.I. Employee Consultant Major

More information

Increasing the Sensitivity of Genomic Assays Permits a Higher Resolution Study of the Human Genome. Our Current Knowledge of Genetics and Genomics

Increasing the Sensitivity of Genomic Assays Permits a Higher Resolution Study of the Human Genome. Our Current Knowledge of Genetics and Genomics Our Current Knowledge of Genetics and Genomics Unlocking the Diagnostic Potential of Genomic Medicine The Beaumont DNA Array Experience Mark Micale, Ph.D., F.A.C.M.G. Medical Director, Clinical Cytogenomics

More information

Clinical Policy Title: Array comparative genomic hybridization testing

Clinical Policy Title: Array comparative genomic hybridization testing Clinical Policy Title: Array comparative genomic hybridization testing Clinical Policy Number: 02.01.03 Policy contains: Chromosomal microarray analysis. Effective Date: September 1, 2015 Comparative genomic

More information

Prior Authorization Review Panel MCO Policy Submission

Prior Authorization Review Panel MCO Policy Submission Prior Authorization Review Panel MCO Policy Submission A separate copy of this form must accompany each policy submitted for review. Policies submitted without this form will not be considered for review.

More information

Genomic structural variation

Genomic structural variation Genomic structural variation Mario Cáceres The new genomic variation DNA sequence differs across individuals much more than researchers had suspected through structural changes A huge amount of structural

More information

Clinical Interpretation of Cancer Genomes

Clinical Interpretation of Cancer Genomes IGENZ Ltd, Auckland, New Zealand Clinical Interpretation of Cancer Genomes Dr Amanda Dixon-McIver www.igenz.co.nz 1992 Slovenia and Croatia gain independence USA and Russia declare the Cold War over Steffi

More information

Canadian College of Medical Geneticists (CCMG) Cytogenetics Examination. May 4, 2010

Canadian College of Medical Geneticists (CCMG) Cytogenetics Examination. May 4, 2010 Canadian College of Medical Geneticists (CCMG) Cytogenetics Examination May 4, 2010 Examination Length = 3 hours Total Marks = 100 (7 questions) Total Pages = 8 (including cover sheet and 2 pages of prints)

More information

Clinical Cytogenomics Laboratory. Laboratory. Leading diagnostics for better medicine. Beaumont

Clinical Cytogenomics Laboratory. Laboratory. Leading diagnostics for better medicine. Beaumont Clinical Cytogenomics Laboratory Leading diagnostics for better medicine Beaumont Laboratory Beaumont Laboratory s Clinical Cytogenomics Lab Genome decoding is essential Knowledge of variations in genome

More information

Genetic Testing for Single-Gene and Multifactorial Conditions

Genetic Testing for Single-Gene and Multifactorial Conditions Clinical Appropriateness Guidelines Genetic Testing for Single-Gene and Multifactorial Conditions EFFECTIVE MARCH 31, 2019 Appropriate.Safe.Affordable 2019 AIM Specialty Health 2069-0319 Table of Contents

More information

Clinical Policy Title: Array comparative genomic hybridization testing

Clinical Policy Title: Array comparative genomic hybridization testing Clinical Policy Title: Array comparative genomic hybridization testing Clinical Policy Number: 02.01.03 Effective Date: Sept 1, 2015 Initial Review Date: May 13, 2013 Most Recent Review Date: September

More information

Section: Genetic Testing Last Reviewed Date: April Policy No: 58 Effective Date: July 1, 2014

Section: Genetic Testing Last Reviewed Date: April Policy No: 58 Effective Date: July 1, 2014 Medical Policy Manual Topic: Genetic Testing, including Chromosomal Microarray Analysis (CMA) and Next Generation Sequencing Panels, for the Genetic Evaluation of Patients with Developmental Delay/Intellectual

More information

GENOME-WIDE ANALYSIS BY SNP ARRAY

GENOME-WIDE ANALYSIS BY SNP ARRAY GENOME-WIDE ANALYSIS BY SNP ARRAY SNP ARRAY IN THE DIAGNOSIS OF INTELLECTUAL DISABILITY AND C O N G E N I T A L ABNORMALITIES Contents Introduction... 3 Conventional and molecular cytogenetics (FISH)...

More information

Structural Chromosome Aberrations

Structural Chromosome Aberrations Structural Chromosome Aberrations 2 Structural chromosome aberrations or chromosome mutations represent apart from aneuploidies the most frequent pathologic findings in applied chromosome diagnostics.

More information

Invasive Prenatal (Fetal) Diagnostic Testing

Invasive Prenatal (Fetal) Diagnostic Testing Protocol Invasive Prenatal (Fetal) Diagnostic Testing (204116) Medical Benefit Effective Date: 04/01/18 Next Review Date: 01/19 Preauthorization Yes Review Dates: 01/15, 01/16, 01/17, 01/18 Preauthorization

More information

Genome-wide analysis by SNP Array

Genome-wide analysis by SNP Array Genome-wide analysis by SNP Array SNP Array in the diagnosis of Mental Retardation and Congenital Abnormalities Contents Introduction...3 Conventional and molecular cytogenetics (FISH)...4 1. Karyotyping...4

More information

Seven cases of intellectual disability analysed by genomewide SNP analysis. Rodney J. Scott

Seven cases of intellectual disability analysed by genomewide SNP analysis. Rodney J. Scott Seven cases of intellectual disability analysed by genomewide SNP analysis Rodney J. Scott Ability to interrogate Genomic Material ~1930 Crude analyses 2012 Highly precise analyses A (very) brief history

More information

Clinical Cytogenetics September 14 th 20 th, 2014 Goldrain, South Tyrol, Italy

Clinical Cytogenetics September 14 th 20 th, 2014 Goldrain, South Tyrol, Italy Thanks for their support to: E.C.A. European Cytogeneticists Association Clinical Cytogenetics September 14 th 20 th, 2014 Goldrain, South Tyrol, Italy DIRECTOR: A. Schinzel (Zurich, Switzerland) FACULTY:

More information

SNP Microarray. Prenatal

SNP Microarray. Prenatal SNP Microarray Prenatal SNP Microarray Reveal SNP Microarray is a test that analyzes chromosomes for changes that can explain certain kinds of birth defects. This brochure is designed to answer some of

More information

Why did this happen? Genetic and teratologic considerations in CHD Jennifer Kussmann, MS,CGC. The Children's Mercy Hospital, 2014.

Why did this happen? Genetic and teratologic considerations in CHD Jennifer Kussmann, MS,CGC. The Children's Mercy Hospital, 2014. Why did this happen? Genetic and teratologic considerations in CHD Jennifer Kussmann, MS,CGC The Children's Mercy Hospital, 2014. 03/14 Risk factors Family history Maternal medical condition/ illness Monochorionic

More information

Human Genetic Variation Copy Number Variation

Human Genetic Variation Copy Number Variation The Evolution of Laboratory Prenatal Diagnosis Lawrence D. Platt, MD Professor of Obstetrics and Gynecology David Geffen School of Medicine at UCLA Center for Fetal Medicine & Women s Ultrasound Los Angeles,

More information

Case Report Prenatal Diagnosis of Cystic Hygroma related to a Deletion of 16q24.1 with Haploinsufficiency of FOXF1 and FOXC2 Genes

Case Report Prenatal Diagnosis of Cystic Hygroma related to a Deletion of 16q24.1 with Haploinsufficiency of FOXF1 and FOXC2 Genes Case Reports in Genetics Volume 2012, Article ID 490408, 4 pages doi:10.1155/2012/490408 Case Report Prenatal Diagnosis of Cystic Hygroma related to a Deletion of 16q24.1 with Haploinsufficiency of FOXF1

More information

Understanding the Human Karyotype Colleen Jackson Cook, Ph.D.

Understanding the Human Karyotype Colleen Jackson Cook, Ph.D. Understanding the Human Karyotype Colleen Jackson Cook, Ph.D. SUPPLEMENTAL READING Nussbaum, RL, McInnes, RR, and Willard HF (2007) Thompson and Thompson Genetics in Medicine, 7th edition. Saunders: Philadelphia.

More information

Case 1B. 46,XY,-14,+t(14;21)

Case 1B. 46,XY,-14,+t(14;21) Case 1B 46,XY,-14,+t(14;21) G-banded Chromosome telomere centromere G-dark bands AT-rich few genes G-pale bands GC-rich many genes telomere ideograms ideograms Conventional (light microscopy) p = short

More information

Updating penetrance estimates for syndromes with variable phenotypic manifestation. Adele Corrigan June 27th

Updating penetrance estimates for syndromes with variable phenotypic manifestation. Adele Corrigan June 27th Updating penetrance estimates for syndromes with variable phenotypic manifestation Adele Corrigan June 27th Background Array CGH has led to increased identification of copy number variants (CNVs) Our understanding

More information

New and Developing Technologies for Genetic Diagnostics National Genetics Reference Laboratory (Wessex) Salisbury, UK - July 2010 BACs on Beads

New and Developing Technologies for Genetic Diagnostics National Genetics Reference Laboratory (Wessex) Salisbury, UK - July 2010 BACs on Beads New and Developing Technologies for Genetic Diagnostics National Genetics Reference Laboratory (Wessex) Salisbury, UK - July 2010 BACs on Beads Susan Gross, MD Division of Reproductive Genetics Professor

More information

22q11.2 DELETION SYNDROME. Anna Mª Cueto González Clinical Geneticist Programa de Medicina Molecular y Genética Hospital Vall d Hebrón (Barcelona)

22q11.2 DELETION SYNDROME. Anna Mª Cueto González Clinical Geneticist Programa de Medicina Molecular y Genética Hospital Vall d Hebrón (Barcelona) 22q11.2 DELETION SYNDROME Anna Mª Cueto González Clinical Geneticist Programa de Medicina Molecular y Genética Hospital Vall d Hebrón (Barcelona) Genomic disorders GENOMICS DISORDERS refers to those diseases

More information

Genetics update and implications for (General) Practice

Genetics update and implications for (General) Practice Genetics update and implications for (General) Practice May 12 th 2018 Women s Health Symposium Clearwater Estate Dr Kate Gibson MB BCh, MRCP, FRACP Topics NZ Clinical Genetics delivery New Technologies

More information

FEP Medical Policy Manual

FEP Medical Policy Manual FEP Medical Policy Manual Effective Date: April 15, 2018 Related Policies: 2.04.122 Chromosomal Microarray Analysis for the Evaluation of Pregnancy Loss 2.04.59 Genetic Testing for Developmental Delay/Intellectual

More information

PROVIDER POLICIES & PROCEDURES

PROVIDER POLICIES & PROCEDURES PROVIDER POLICIES & PROCEDURES COMPARATIVE GENOMIC HYBRIDIZATION (CGH) MICROARRAY TESTING FOR DEVELOPMENTAL DELAY, AUTISM SPECTRUM DISORDER AND INTELLECTUAL DISABILITY The purpose of this policy is to

More information

Addressing the challenges of genomic characterization of hematologic malignancies using microarrays

Addressing the challenges of genomic characterization of hematologic malignancies using microarrays Addressing the challenges of genomic characterization of hematologic malignancies using microarrays Sarah South, PhD, FACMG Medical Director, ARUP Laboratories Department of Pediatrics and Pathology University

More information

(2018) Keywords: Balanced rearrangement; Chromosomal microarray; genetic testing; mosaicism; UPD

(2018) Keywords: Balanced rearrangement; Chromosomal microarray; genetic testing; mosaicism; UPD American College of Medical Genetics and Genomics Yield of additional genetic testing after chromosomal microarray for diagnosis of neurodevelopmental disability and congenital anomalies: a clinical practice

More information

Clinical Genomics. Ina E. Amarillo, PhD FACMGG

Clinical Genomics. Ina E. Amarillo, PhD FACMGG Clinical Genomics Ina E. Amarillo, PhD FACMGG Associate Medical Director, Cytogenetics Lab (CaTG), Lab and Genomic Medicine Assistant Professor, Pathology and Immunology Outline Clinical Genomics Testing

More information

Association for Molecular Pathology Promoting Clinical Practice, Basic Research, and Education in Molecular Pathology

Association for Molecular Pathology Promoting Clinical Practice, Basic Research, and Education in Molecular Pathology Association for Molecular Pathology Promoting Clinical Practice, Basic Research, and Education in Molecular Pathology 9650 Rockville Pike, Bethesda, Maryland 20814 Tel: 301-634-7939 Fax: 301-634-7990 Email:

More information

Chromosome Microarray Analysis (CMA)

Chromosome Microarray Analysis (CMA) Chromosome Microarray Analysis (CMA) Ina E. Amarillo, PhD FACMG Cytogenomics Lab (Associate Medical Director) Pathology (Assistant Professor) OUTLINE Clinical Indications for Cytogenomics Testing Cytogenomics

More information

GENETICS ROTATION OBJECTIVES MATERNAL-FETAL MEDICINE FELLOWSHIP

GENETICS ROTATION OBJECTIVES MATERNAL-FETAL MEDICINE FELLOWSHIP GENETICS ROTATION OBJECTIVES MATERNAL-FETAL MEDICINE FELLOWSHIP University of New Mexico 1. General Description: UNM MFM fellows rotate through genetics during their PGY5 and PGY7 years. The PGY5 fellow

More information

Application of Whole Genome Microarrays in Cancer: You should be doing this test!!

Application of Whole Genome Microarrays in Cancer: You should be doing this test!! Application of Whole Genome Microarrays in Cancer: You should be doing this test!! Daynna Wolff, Ph.D. Director, Cytogenetics and Genomics Disclosures Clinical Laboratory Director and Employee, Medical

More information

MP Genetic Testing for Developmental Delay/Intellectual Disability, Autism Spectrum Disorder, and Congenital Anomalies

MP Genetic Testing for Developmental Delay/Intellectual Disability, Autism Spectrum Disorder, and Congenital Anomalies Medical Policy Genetic Testing for Developmental Delay/Intellectual Disability, Autism Spectrum Disorder, and Congenital BCBSA Ref. Policy: 2.04.59 Last Review: 10/18/2018 Effective Date: 10/18/2018 Section:

More information

Genetics and Genomics: Applications to Developmental Disability

Genetics and Genomics: Applications to Developmental Disability Tuesday, 12:30 2:00, B1 Objective: Genetics and Genomics: Applications to Developmental Disability Helga Toriello 616-234-2712 toriello@msu.edu Identify advances in clinical assessment and management of

More information

SNP array-based analyses of unbalanced embryos as a reference to distinguish between balanced translocation carrier and normal blastocysts

SNP array-based analyses of unbalanced embryos as a reference to distinguish between balanced translocation carrier and normal blastocysts J Assist Reprod Genet (2016) 33:1115 1119 DOI 10.1007/s10815-016-0734-0 TECHNOLOGICAL INNOVATIONS SNP array-based analyses of unbalanced embryos as a reference to distinguish between balanced translocation

More information

Investigating rare diseases with Agilent NGS solutions

Investigating rare diseases with Agilent NGS solutions Investigating rare diseases with Agilent NGS solutions Chitra Kotwaliwale, Ph.D. 1 Rare diseases affect 350 million people worldwide 7,000 rare diseases 80% are genetic 60 million affected in the US, Europe

More information

Diagnosis of parental balanced reciprocal translocations by trophectoderm biopsy and comprehensive chromosomal screening

Diagnosis of parental balanced reciprocal translocations by trophectoderm biopsy and comprehensive chromosomal screening Diagnosis of parental balanced reciprocal translocations by trophectoderm biopsy and comprehensive chromosomal screening Lian Liu, MD Co-Authors: L. W. Sundheimer1, L. Liu2, R. P. Buyalos1,3, G. Hubert1,3,

More information

FEP Medical Policy Manual

FEP Medical Policy Manual FEP Medical Policy Manual 2.04.59 Genetic Testing for Developmental Delay/Intellectual Disability, Autism Spectrum Disorder, Last Review: December 2016 Effective Date: January 15, 2017 Related Policies:

More information

No mutations were identified.

No mutations were identified. Hereditary High Cholesterol Test ORDERING PHYSICIAN PRIMARY CONTACT SPECIMEN Report date: Aug 1, 2017 Dr. Jenny Jones Sample Medical Group 123 Main St. Sample, CA Kelly Peters Sample Medical Group 123

More information

Most severely affected will be the probe for exon 15. Please keep an eye on the D-fragments (especially the 96 nt fragment).

Most severely affected will be the probe for exon 15. Please keep an eye on the D-fragments (especially the 96 nt fragment). SALSA MLPA probemix P343-C3 Autism-1 Lot C3-1016. As compared to version C2 (lot C2-0312) five reference probes have been replaced, one reference probe added and several lengths have been adjusted. Warning:

More information

Global variation in copy number in the human genome

Global variation in copy number in the human genome Global variation in copy number in the human genome Redon et. al. Nature 444:444-454 (2006) 12.03.2007 Tarmo Puurand Study 270 individuals (HapMap collection) Affymetrix 500K Whole Genome TilePath (WGTP)

More information

review Genetics IN Medicine 13

review Genetics IN Medicine 13 January 2008 Vol. 10 No. 1 review Pre- and postnatal genetic testing by array-comparative genomic hybridization: genetic counseling perspectives Sandra Darilek, MS, Patricia Ward, MS, Amber Pursley, MS,

More information

Number: Policy *Please see amendment for Pennsylvania Medicaid at the end of this CPB.

Number: Policy *Please see amendment for Pennsylvania Medicaid at the end of this CPB. Number: 0787 Policy *Please see amendment for Pennsylvania Medicaid at the end of this CPB. Aetna considers comparative genomic hybridization (CGH) medically necessary for the following indications: Evaluating

More information

CNV detection. Introduction and detection in NGS data. G. Demidov 1,2. NGSchool2016. Centre for Genomic Regulation. CNV detection. G.

CNV detection. Introduction and detection in NGS data. G. Demidov 1,2. NGSchool2016. Centre for Genomic Regulation. CNV detection. G. Introduction and detection in NGS data 1,2 1 Genomic and Epigenomic Variation in Disease group, Centre for Genomic Regulation 2 Universitat Pompeu Fabra NGSchool2016 methods: methods Outline methods: methods

More information

%(6/31) [DOI] /j.issn

%(6/31) [DOI] /j.issn 750 2016 9 1 41 9 [ ] 2012 2 2015 5 31 20~37 21~27 31 G 4 1 26 23 3 11.54%(3/26) 4 / 21 6 19.35%(6/31) [ ] [ ] R714.53 [ ] A [ ] 0577-7402(2016)09-0750-08 [DOI] 10.11855/j.issn.0577-7402.2016.09.10 Application

More information

LIST OF INVESTIGATIONS

LIST OF INVESTIGATIONS Karyotyping: K001 K002 LIST OF INVESTIGATIONS SAMPLE CONTAINER TYPE cells For Karyotyping [Single] cells For Karyotyping [Couple] Vacutainer Vacutainer 7-8 7-8 K003 Fetal Blood Sample For Karyotyping Vacutainer

More information

Genomic complexity and arrays in CLL. Gian Matteo Rigolin, MD, PhD St. Anna University Hospital Ferrara, Italy

Genomic complexity and arrays in CLL. Gian Matteo Rigolin, MD, PhD St. Anna University Hospital Ferrara, Italy Genomic complexity and arrays in CLL Gian Matteo Rigolin, MD, PhD St. Anna University Hospital Ferrara, Italy Clinical relevance of genomic complexity (GC) in CLL GC has been identified as a critical negative

More information

Structural Variation and Medical Genomics

Structural Variation and Medical Genomics Structural Variation and Medical Genomics Andrew King Department of Biomedical Informatics July 8, 2014 You already know about small scale genetic mutations Single nucleotide polymorphism (SNPs) Deletions,

More information

Current controversies in prenatal diagnosis 3: is conventional chromosome analysis necessary in the post-array CGH era?

Current controversies in prenatal diagnosis 3: is conventional chromosome analysis necessary in the post-array CGH era? PRENATAL DIAGNOSIS Prenat Diagn 2011; 31: 235 243. Published online 10 February 2011 in Wiley Online Library (wileyonlinelibrary.com).2722 DEBATE Current controversies in prenatal diagnosis 3: is conventional

More information

Dr Dipti Deshmukh. Mayu Uemura. 11th September Introduction

Dr Dipti Deshmukh. Mayu Uemura. 11th September Introduction Genetic Findings in Children with Unexplained Developmental Delay Dr Dipti Deshmukh Neurodevelopmental Consultant, St. George's Hospital, London Mayu Uemura 4th year MBBS4, St George s University of London

More information

7.1 Molecular Characterization of Fragile X Syndrome

7.1 Molecular Characterization of Fragile X Syndrome 7 GENETIC DISORDERS Advances in knowledge of molecular genetics, cytogenetics and biochemical genetics have led to availability of diagnostic tests for various genetic disorders. The most important application

More information

increment in the genome to calculate the statistic of read count. Three billions according to the reference

increment in the genome to calculate the statistic of read count. Three billions according to the reference SUPPLEMENTAL METHODS Genome-wide Window Determination As described in our previous study 1, we use adjustable sliding windows with increment in the genome to calculate the statistic of read count. Three

More information

RACP Congress 2017 Genetics of Intellectual Disability and Autism: Past Present and Future 9 th May 2017

RACP Congress 2017 Genetics of Intellectual Disability and Autism: Past Present and Future 9 th May 2017 RACP Congress 2017 Genetics of Intellectual Disability and Autism: Past Present and Future 9 th May 2017 Why causation? Explanation for family Prognosis Recurrence risk and reproductive options Guide medical

More information

Chromosome Abnormalities

Chromosome Abnormalities Chromosome Abnormalities Chromosomal abnormalities vs. molecular mutations Simply a matter of size Chromosomal abnormalities are big errors Two types of abnormalities 1. Constitutional problem present

More information

Copy Number Variants of Uncertain Significance in Prenatal diagnosis Are the Goalposts Moving? Lisa Burvill-Holmes Bristol Genetics Laboratory

Copy Number Variants of Uncertain Significance in Prenatal diagnosis Are the Goalposts Moving? Lisa Burvill-Holmes Bristol Genetics Laboratory Copy Number Variants of Uncertain Significance in Prenatal diagnosis Are the Goalposts Moving? Lisa Burvill-Holmes Bristol Genetics Laboratory http://www.nbt.nhs.uk/genetics Microarray CGH in Prenatal

More information

Research Article Prenatal Diagnosis of Central Nervous System Anomalies by High-Resolution Chromosomal Microarray Analysis

Research Article Prenatal Diagnosis of Central Nervous System Anomalies by High-Resolution Chromosomal Microarray Analysis Hindawi Publishing Corporation BioMed Research International Volume 2015, Article ID 426379, 9 pages http://dx.doi.org/10.1155/2015/426379 Research Article Prenatal Diagnosis of Central Nervous System

More information

MPS for translocations

MPS for translocations MPS for translocations Filip Van Nieuwerburgh, Ph.D. Lab of Pharmaceutical Biotechnology NXTGNT massively parallel sequencing facility, Ghent University In collaboration with: Center for Medical Genetics,

More information

Detection of aneuploidy in a single cell using the Ion ReproSeq PGS View Kit

Detection of aneuploidy in a single cell using the Ion ReproSeq PGS View Kit APPLICATION NOTE Ion PGM System Detection of aneuploidy in a single cell using the Ion ReproSeq PGS View Kit Key findings The Ion PGM System, in concert with the Ion ReproSeq PGS View Kit and Ion Reporter

More information

Targeted qpcr. Debate on PGS Technology: Targeted vs. Whole genome approach. Discolsure Stake shareholder of GENETYX S.R.L

Targeted qpcr. Debate on PGS Technology: Targeted vs. Whole genome approach. Discolsure Stake shareholder of GENETYX S.R.L Antonio Capalbo, PhD Laboratory Director GENETYX, reproductive genetics laboratory, Italy PGT responsible GENERA centers for reproductive medicine, Italy Debate on PGS Technology: Targeted vs. Whole genome

More information

Molecular and Clinical Characterization of Syndromes Associated With Intellectual Disability

Molecular and Clinical Characterization of Syndromes Associated With Intellectual Disability Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 880 Molecular and Clinical Characterization of Syndromes Associated With Intellectual Disability CHRISTIAN WENTZEL

More information

chromosomal anomalies and mental pdf Chapter 8: Chromosomes and Chromosomal Anomalies (PDF) Chromosomal abnormalities -A review - ResearchGate

chromosomal anomalies and mental pdf Chapter 8: Chromosomes and Chromosomal Anomalies (PDF) Chromosomal abnormalities -A review - ResearchGate DOWNLOAD OR READ : CHROMOSOMAL ANOMALIES AND MENTAL RETARDATION FROM GENOTYPES TO NEUROPSYCHOLOGICAL PHENOTYPES OF GENETIC SYNDROMES AT HIGH INCIDENCEGENOTYPE TO PHENOTYPE PDF EBOOK EPUB MOBI Page 1 Page

More information

What lies beneath: challenges in reporting SNP array results. Jonathan Waters

What lies beneath: challenges in reporting SNP array results. Jonathan Waters What lies beneath: challenges in reporting SNP array results Jonathan Waters Challenges in variant interpretation Austin Court, Birmingham Monday 4 th July 2016 What lies beneath: challenges in reporting

More information